BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37428606)

  • 1. Therapeutic Potential of PTB Inhibition Through Converting Glial Cells to Neurons in the Brain.
    Fu XD; Mobley WC
    Annu Rev Neurosci; 2023 Jul; 46():145-165. PubMed ID: 37428606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease.
    Chen W; Zheng Q; Huang Q; Ma S; Li M
    Elife; 2022 May; 11():. PubMed ID: 35535997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulating PTBP1 Fails to Convert Astrocytes into Hippocampal Neurons and to Alleviate Symptoms in Alzheimer's Mouse Models.
    Guo T; Pan X; Jiang G; Zhang D; Qi J; Shao L; Wang Z; Xu H; Zhao Y
    J Neurosci; 2022 Sep; 42(38):7309-7317. PubMed ID: 35944999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New AAV tools fail to detect Neurod1-mediated neuronal conversion of Müller glia and astrocytes in vivo.
    Xie Y; Zhou J; Wang LL; Zhang CL; Chen B
    EBioMedicine; 2023 Apr; 90():104531. PubMed ID: 36947961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases.
    Contardo M; De Gioia R; Gagliardi D; Comi GP; Ottoboni L; Nizzardo M; Corti S
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing a model of Parkinson's disease with in situ converted nigral neurons.
    Qian H; Kang X; Hu J; Zhang D; Liang Z; Meng F; Zhang X; Xue Y; Maimon R; Dowdy SF; Devaraj NK; Zhou Z; Mobley WC; Cleveland DW; Fu XD
    Nature; 2020 Jun; 582(7813):550-556. PubMed ID: 32581380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical examination of Ptbp1-mediated glia-to-neuron conversion in the mouse retina.
    Xie Y; Zhou J; Chen B
    Cell Rep; 2022 Jun; 39(11):110960. PubMed ID: 35705044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of PTBP1 Inhibition, If Any, Is Not Attributed to Glia-to-Neuron Conversion.
    Wang LL; Zhang CL
    Annu Rev Neurosci; 2023 Jul; 46():1-15. PubMed ID: 36750409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal conversion from glia to replenish the lost neurons.
    Liang S; Zhou J; Yu X; Lu S; Liu R
    Neural Regen Res; 2024 Jul; 19(7):1446-1453. PubMed ID: 38051886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk signals in the CNS: role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network.
    Marchetti B
    Front Biosci; 1997 Mar; 2():d88-125. PubMed ID: 9159216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice.
    Zhou H; Su J; Hu X; Zhou C; Li H; Chen Z; Xiao Q; Wang B; Wu W; Sun Y; Zhou Y; Tang C; Liu F; Wang L; Feng C; Liu M; Li S; Zhang Y; Xu H; Yao H; Shi L; Yang H
    Cell; 2020 Apr; 181(3):590-603.e16. PubMed ID: 32272060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
    Yang Y; Yang S; Guo J; Cui Y; Tang B; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(38):9101-9115. PubMed ID: 28821675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glia as a turning point in the therapeutic strategy of Parkinson's disease.
    L' Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):349-72. PubMed ID: 20438439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glia-neuron intercommunications and synaptic plasticity.
    Vernadakis A
    Prog Neurobiol; 1996 Jun; 49(3):185-214. PubMed ID: 8878303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury.
    Liu J; Xin X; Sun J; Fan Y; Zhou X; Gong W; Yang M; Li Z; Wang Y; Yang Y; Gao C
    Neural Regen Res; 2024 Mar; 19(3):629-635. PubMed ID: 37721294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte lineage cells are essential for functional neuronal differentiation and synapse maturation in human iPSC-derived neural networks.
    Klapper SD; Garg P; Dagar S; Lenk K; Gottmann K; Nieweg K
    Glia; 2019 Oct; 67(10):1893-1909. PubMed ID: 31246351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-Astrocyte Interactions in Parkinson's Disease.
    Miyazaki I; Asanuma M
    Cells; 2020 Dec; 9(12):. PubMed ID: 33297340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo glia-to-neuron conversion: pitfalls and solutions.
    Wang LL; Zhang CL
    Dev Neurobiol; 2022 Jul; 82(5):367-374. PubMed ID: 35535734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature astrocytes transform into transitional radial glia within adult mouse neocortex that supports directed migration of transplanted immature neurons.
    Leavitt BR; Hernit-Grant CS; Macklis JD
    Exp Neurol; 1999 May; 157(1):43-57. PubMed ID: 10222107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.